Skip to content

AI-led cancer research project in Dresden aims to enhance understanding and treatment of cancer

AI-driven Cancer Research in Dresden: Enhancing Cancer Treatment through Artificial Intelligence

Artificial Intelligence endeavor in Dresden: Advancing cancer diagnosis and therapy through AI...
Artificial Intelligence endeavor in Dresden: Advancing cancer diagnosis and therapy through AI technology

AI-led cancer research project in Dresden aims to enhance understanding and treatment of cancer

In the heart of Dresden, Germany, a groundbreaking research project named DECIPHER-M is underway. Coordinated by Prof. Jakob Nikolas Kather, this multimodal initiative is set to revolutionise the understanding and treatment of cancer metastasis.

The project, scheduled to take place between this year and 2030, has a five-year duration and an initial budget of approximately 5.5 million euros, funded by the Federal Ministry of Education and Research (BMBF) for the first three years. The aim is to ultimately secure around nine million euros in total.

The DECIPHER-M project is focused on understanding the spread of cancer cells, a process known as metastasis. This spread makes cancer harder to treat, often leading to a poorer prognosis for patients. By developing personalised treatment strategies for individual metastasis risk prediction, the project seeks to enable earlier, more precise diagnoses and preventive measures.

The approach taken by the project is multimodal, connecting various types of data. This includes tissue samples, X-ray images, and genetic information, all of which are to be analysed using artificial intelligence (AI). The ultimate goal is to create a comprehensive "big picture" of cancer spread, which could lead to new therapeutic approaches and improved treatment options.

The project is not limited to the Technical University of Dresden. Partners from multiple German cities, including Aachen, Essen, Heidelberg, Mainz, and Munich, are involved in the project. However, the further partners of the DECIPHER-M project partnership have not yet been specified.

The project's ultimate aim is to improve the survival rates of cancer patients, making a significant impact on the lives of those affected by this devastating disease. As the project progresses, we can look forward to a brighter future in the fight against cancer.

Read also:

Latest